TIAA CREF INVESTMENT MANAGEMENT LLC - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is PRTK and the CUSIP is 699374302. A total of 93 filers reported holding PARATEK PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 3.64 and the average weighting 0.7%.

Quarter-by-quarter ownership
TIAA CREF INVESTMENT MANAGEMENT LLC ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q1 2019$336,000
+5.7%
62,711
+1.1%
0.00%
Q4 2018$318,000
-74.1%
62,041
-50.9%
0.00%
Q3 2018$1,226,000
+86.3%
126,444
+96.0%
0.00%
Q2 2018$658,000
-63.3%
64,512
-53.2%
0.00%
-100.0%
Q1 2018$1,794,000
+9.3%
137,983
+50.5%
0.00%0.0%
Q4 2017$1,642,000
+2.4%
91,711
+43.5%
0.00%0.0%
Q3 2017$1,604,000
-28.5%
63,915
-31.3%
0.00%
-50.0%
Q2 2017$2,242,000
+55.2%
93,047
+23.9%
0.00%
+100.0%
Q1 2017$1,445,000
+39.6%
75,076
+11.7%
0.00%0.0%
Q4 2016$1,035,000
+39.7%
67,232
+18.1%
0.00%
Q3 2016$741,000
+9.9%
56,930
+17.5%
0.00%
-100.0%
Q2 2016$674,000
+9.2%
48,462
+19.2%
0.00%
Q1 2016$617,000
-20.0%
40,6580.0%0.00%
-100.0%
Q4 2015$771,000
-16.9%
40,658
-16.8%
0.00%0.0%
Q3 2015$928,000
-10.8%
48,855
+21.1%
0.00%0.0%
Q2 2015$1,040,00040,3550.00%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q4 2016
NameSharesValueWeighting ↓
Omega Fund Management, LLC 2,600,410$13,340,0009.89%
Abingworth LLP 1,041,131$5,341,0004.85%
Roumell Asset Management, LLC 450,406$2,311,0004.78%
HIGHLAND CAPITAL MANAGEMENT LP 2,391,993$12,271,0000.94%
Trellus Management Company, LLC 71,200$365,0000.82%
ARMISTICE CAPITAL, LLC 1,968,000$10,096,0000.76%
Arbiter Partners Capital Management LLC 1,111,936$5,704,0000.64%
Fortress Investment Group LLC 433,804$2,226,0000.27%
GENERAL AMERICAN INVESTORS CO INC 464,985$2,385,0000.25%
WATER ISLAND CAPITAL LLC 318,518$1,634,0000.12%
View complete list of PARATEK PHARMACEUTICALS INC shareholders